Venous Thromboembolism – Current Diagnostic and Treatment Modalities
DOI:
https://doi.org/10.3889/oamjms.2016.087Keywords:
venous thromboembolism, pulmonary embolism, deep venous thrombosis treatment, novel oral anticoagulantsAbstract
BACKGROUND: Pulmonary embolism and deep venous thrombosis, known as venous thromboembolism (VTE), are associated with a high proportion of morbidity and mortality.
AIM: Aim of this review is to emphasise current diagnostic and therapeutic modalities for VTE.
RESULTS: No differences have been noticed in European and American guidelines in diagnostic approach of this disorder. Today there is enough clinical information for the use of heparin (either, unfractionated or low molecular) and vitamin K antagonists in the treatment of acute and chronic phases of VTE. Novel oral anticoagulants seem to have some advantages in the treatment of this disorder. Rivaroxaban has been approved widespread, for use as a single-drug approach of VTE.
CONCLUSION: Both guidelines are almost similar and good basis for evidence-based treatment of this disorder.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Monreal M, Mahé I, Bura-Riviere A, Prandoni P, Verhamme P, Brenner B, Wells PS, Di Micco P, Bertoletti L. Pulmonary embolism: Epidemiology and registries. Presse Med. 2015;44(12 Pt 2):e377-83. http://dx.doi.org/10.1016/j.lpm.2015.10.006 PMid:26547675
Skhiri M, Hunt SA, Denault AY, Haddad F. Evidence-Based Managеmеnt of Right Heart Failure: a Systematic Review of an Empiric Field. Rev Esp Cardiol. 2010;63(4):451-71. http://dx.doi.org/10.1016/S0300-8932(10)70066-X
Jiménez D, de Miguel-DÃez J, Guijarro R, Trujillo-Santos J, Otero R, Barba R, Muriel A, Meyer G, Yusen RD, Monreal M; RIETE Investigators.Trends in the Management and Outcomes of Acute Pulmonary Embolism: Analysis From the RIETE Registry. J Am Coll Cardiol. 2016;67(2):162-70. http://dx.doi.org/10.1016/j.jacc.2015.10.060 PMid:26791063
Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JR, Wells P, Woller SC, Moores L. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest. 2016;149(2):315-52. http://dx.doi.org/10.1016/j.chest.2015.11.026 PMid:26867832
SEC Working Group for the ESC 2014 Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism; Expert Reviewers for the ESC 2014 Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism; SEC Clinical Practice Guidelines Committee. Comments on the 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Rev Esp Cardiol (Engl Ed). 2015;68(1):10-6.
Moliterno DJ, Kristensen SD, De Caterina R. Therapeutic advances in thrombosis. Second edition. Wiley-Blackwel, 2013.
DeLoughery G. Hemostasis and Thrombosis. 3rd Edition. Spinger, 2015. http://dx.doi.org/10.1007/978-3-319-09312-3
Toth PP. Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era. Vasc Health Risk Manag. 2016;12:23-34. http://dx.doi.org/10.2147/VHRM.S88088 PMid:26929637 PMCid:PMC4754098
Martinez K, Kosirog E, Billups SJ, Clark NP, Delate T, Witt DM. Clinical outcomes and adherence to guideline recommendations during the initial treatment of acute venous thromboembolism. Ann Pharmacother. 2015;49(8):869-75. http://dx.doi.org/10.1177/1060028015583892 PMid:25931575
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0